About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« Gene Therapy Experiencing a Revival | Main | Avid Identification Systems, Inc. v. Crystal Import Corp. (Fed. Cir. 2010) »

May 03, 2010


"The Federal Circuit commented on the irony that it was precisely because ALZA argued for broader claim construction that its claims were found to be invalid. The Court failed, however, to mention that ALZA may have been required to argue for the broader construction in order for the claims to cover Andrx's ANDA product."

That's a strange way to use the word "required," Kevin. ALZA wasn't "required" to do anything here. ALZA was greedy and they got burned. Now watch ALZA collect the money they spent on this case from their customers, in the form of increased prices.

And the defendant will do the same, of course.

Isn't greed wonderful? 12 years of data exclusivity for these creeps.

ALZA has done the right thing, by arguing the border Construction. and claimed to cover Andrix.

The comments to this entry are closed.

April 2024

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30